AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $894,000 | +149.7% | 59,040 | +50.0% | 0.00% | – |
| Q1 2022 | $358,000 | -93.8% | 39,350 | -86.0% | 0.00% | -100.0% |
| Q3 2019 | $5,731,000 | +7.1% | 282,000 | +55.8% | 0.01% | +12.5% |
| Q2 2019 | $5,349,000 | +11.6% | 181,011 | +79.4% | 0.01% | 0.0% |
| Q1 2019 | $4,791,000 | -14.6% | 100,871 | -36.1% | 0.01% | -20.0% |
| Q4 2018 | $5,613,000 | -18.7% | 157,961 | +40.9% | 0.01% | 0.0% |
| Q3 2018 | $6,900,000 | +114.0% | 112,101 | +134.8% | 0.01% | +100.0% |
| Q2 2018 | $3,225,000 | +2.6% | 47,741 | -17.6% | 0.01% | 0.0% |
| Q1 2018 | $3,142,000 | -4.1% | 57,910 | +9.2% | 0.01% | +25.0% |
| Q4 2017 | $3,278,000 | +19.3% | 53,020 | -6.2% | 0.00% | 0.0% |
| Q3 2017 | $2,747,000 | -36.7% | 56,520 | -31.6% | 0.00% | -33.3% |
| Q2 2017 | $4,340,000 | +50.6% | 82,590 | +30.0% | 0.01% | +50.0% |
| Q1 2017 | $2,881,000 | – | 63,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |